Literature DB >> 19940800

Skin disease among human immunodeficiency virus-infected adolescents in Zimbabwe: a strong indicator of underlying HIV infection.

Sara Lowe1, Rashida A Ferrand, Rachael Morris-Jones, Jon Salisbury, Nicholas Mangeya, Munyaradzi Dimairo, Robert F Miller, Elizabeth L Corbett.   

Abstract

BACKGROUND: Southern Africa is witnessing the emergence of an epidemic of long-term survivors of vertically acquired human immunodeficiency virus (HIV) infection presenting with untreated HIV as adolescents. Dermatologic conditions, common in both HIV-infected adults and children, have not been described in this age-group. We investigated the prevalence and spectrum of skin conditions in adolescents admitted to hospitals in Zimbabwe.
METHODS: A total of 301 consecutive adolescents admitted to 2 central Harare hospitals, underwent a dermatologic examination. Clinical history, HIV serology, and CD4 lymphocyte counts were obtained. Herpes simplex virus-2 serology was used as a surrogate marker for sexual activity.
RESULTS: : A total of 139 (46%) patients were HIV-1 antibody positive, of whom only 2 (1.4%) were herpes simplex virus-2 antibody positive. The prevalence of any skin complaint among HIV-infected and uninfected participants was 88% and 14%, respectively (odds ratio: 37.7, 95% confidence interval: 19.4-72). The most common HIV-related conditions were pruritic papular eruptions (42%) and plane warts >5% of body area (24%). Having 3 or more skin conditions, a history of recurrent skin rashes and angular cheilitis were each associated with CD4 counts <200 cells/microL (P < 0.03, P < 0.01, and P < 0.05, respectively).
CONCLUSIONS: Skin disease was a common and striking feature of underlying HIV-infection in hospitalized HIV-infected adolescents in Zimbabwe. In resource-poor settings with maturing epidemics, the presence of skin disease should be regarded as a strong indication for HIV testing and especially as it may reflect advanced immunosuppression. The high frequency of multiple plane warts has not previously been described, and may be a feature that distinguishes vertically-infected from horizontally-infected adolescents.

Entities:  

Mesh:

Year:  2010        PMID: 19940800      PMCID: PMC3428906          DOI: 10.1097/INF.0b013e3181c15da4

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  36 in total

Review 1.  HIV-related skin diseases.

Authors:  E Tschachler; P R Bergstresser; G Stingl
Journal:  Lancet       Date:  1996-09-07       Impact factor: 79.321

2.  Correlation of skin disorders with CD4 lymphocyte counts in patients with HIV/AIDS.

Authors:  B Goldstein; B Berman; E Sukenik; S J Frankel
Journal:  J Am Acad Dermatol       Date:  1997-02       Impact factor: 11.527

3.  Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.

Authors:  E Seoane Reula; J M Bellon; D Gurbindo; M A Muñoz-Fernandez
Journal:  Br J Dermatol       Date:  2005-08       Impact factor: 9.302

4.  Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression.

Authors:  W Boonchai; R Laohasrisakul; J Manonukul; K Kulthanan
Journal:  Int J Dermatol       Date:  1999-05       Impact factor: 2.736

5.  Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics.

Authors:  Milly Marston; Basia Zaba; Joshua A Salomon; Heena Brahmbhatt; Danstan Bagenda
Journal:  J Acquir Immune Defic Syndr       Date:  2005-02-01       Impact factor: 3.731

6.  Etiology of pruritic papular eruption with HIV infection in Uganda.

Authors:  Jack S Resneck; Marta Van Beek; Lisa Furmanski; Jessica Oyugi; Philip E LeBoit; Elly Katabira; Fred Kambugu; Toby Maurer; Tim Berger; Mark J Pletcher; Edward L Machtinger
Journal:  JAMA       Date:  2004-12-01       Impact factor: 56.272

7.  Skin disease: clinical indicator of immune status in human immunodeficiency virus (HIV) infection.

Authors:  P V Krishnam Raju; G Raghurama Rao; T V Ramani; S Vandana
Journal:  Int J Dermatol       Date:  2005-08       Impact factor: 2.736

8.  Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania.

Authors:  A Obasi; F Mosha; M Quigley; Z Sekirassa; T Gibbs; K Munguti; J Todd; H Grosskurth; P Mayaud; J Changalucha; D Brown; D Mabey; R Hayes
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

9.  Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children.

Authors:  Danstan Bagenda; Annette Nassali; Israel Kalyesubula; Becky Sherman; Dennis Drotar; Michael J Boivin; Karen Olness
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

10.  Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse.

Authors:  M A Muñoz-Pérez; A Rodriguez-Pichardo; F Camacho; M A Colmenero
Journal:  Br J Dermatol       Date:  1998-07       Impact factor: 9.302

View more
  17 in total

1.  Supporting adolescent orphan girls to stay in school as HIV risk prevention: evidence from a randomized controlled trial in Zimbabwe.

Authors:  Denise Hallfors; Hyunsan Cho; Simbarashe Rusakaniko; Bonita Iritani; John Mapfumo; Carolyn Halpern
Journal:  Am J Public Health       Date:  2011-04-14       Impact factor: 9.308

Review 2.  Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges.

Authors:  Elizabeth D Lowenthal; Sabrina Bakeera-Kitaka; Tafireyi Marukutira; Jennifer Chapman; Kathryn Goldrath; Rashida A Ferrand
Journal:  Lancet Infect Dis       Date:  2014-01-07       Impact factor: 25.071

3.  Chest radiography patterns in 75 adolescents with vertically-acquired human immunodeficiency virus (HIV) infection.

Authors:  S R Desai; S J Copley; R D Barker; C M Elston; R F Miller; A U Wells; S Munyati; K Nathoo; E L Corbett; R A Ferrand
Journal:  Clin Radiol       Date:  2010-12-23       Impact factor: 2.350

4.  Acquired epidermodysplasia verruciformis due to multiple and unusual HPV infection among vertically-infected, HIV-positive adolescents in Zimbabwe.

Authors:  S M Lowe; L Katsidzira; R Meys; J C Sterling; M de Koning; W Quint; K Nathoo; S Munyati; C E Ndhlovu; J R Salisbury; C B Bunker; E L Corbett; R F Miller; R A Ferrand
Journal:  Clin Infect Dis       Date:  2012-04-03       Impact factor: 9.079

5.  Pruritic papular eruptions as presenting illness of HIV.

Authors:  Smriti Naswa; Ravi Khambhati; Y S Marfatia
Journal:  Indian J Sex Transm Dis AIDS       Date:  2011-07

Review 6.  Chronic itch in African Americans: an unmet need.

Authors:  Giuseppe Ingrasci; Nour El-Kashlan; Andrew Alexis; Gil Yosipovitch
Journal:  Arch Dermatol Res       Date:  2021-06-15       Impact factor: 3.017

Review 7.  Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents.

Authors:  Allison L Agwu; Lee Fairlie
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

8.  Burden of HIV among primary school children and feasibility of primary school-linked HIV testing in Harare, Zimbabwe: a mixed methods study.

Authors:  Tsitsi Bandason; Lisa F Langhaug; Memory Makamba; Sue Laver; Karin Hatzold; Stephen Mahere; Shungu Munyati; Stanley Mungofa; Elizabeth L Corbett; Rashida A Ferrand
Journal:  AIDS Care       Date:  2013-03-26

9.  Allergic diseases in subjects under 18 years living with HIV.

Authors:  Leandro S Linhar; Jefferson Traebert; Dayani Galato; Rosemeri M da Silva; Fabiana Schuelter-Trevisol; Natália S Rovaris; Jane da Silva
Journal:  Allergy Asthma Clin Immunol       Date:  2014-07-07       Impact factor: 3.406

Review 10.  Treatment of Dermatological Conditions Associated with HIV/AIDS: The Scarcity of Guidance on a Global Scale.

Authors:  Suchismita Paul; Rachel Evans; Toby Maurer; Lulu M Muhe; Esther E Freeman
Journal:  AIDS Res Treat       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.